Arkolith/Insider Trading/LXRX/Form 4

Artal Group S.A.

Director, 10% OwnerLEXICON PHARMACEUTICALS, INC. (LXRX) · full profile →Form 4 · filed Feb 4, 2026
Net Buying
Open-Market Buys
$2.0M
Open-Market Sells
$0
Net Open-Market Flow
$2.0M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 2, 2026Buy(P)1.5M$1.30$2.0M1.5M
Feb 2, 2026Grant(A)3.8M$1.30$5.0M7.4M
Feb 2, 2026Grant(A)18.6M$1.30$24.1M154.7M
Feb 2, 2026Grant(A)367K$65.00$23.9M367K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-037644) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML